{"SPADE_N_13516": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13516", "Peptide Name": "RNase 8 (Ribonuclease family, antimicrobial protein; natural AMPs; human, primates, mammals, animals; UCSS1a; 4S=S,)", "Source": "Homo sapiens", "Family": "Not found", "Gene": "Not found", "Sequence": "KPKDMTSSQWFKTQHVQPSPQACNSAMSIINKYTERCKDLNTFLHEPFSSVAITCQTPNIACKNSCKNCHQSHGPMSLTMGELTSGKYPNCRYKEKHLNTPYIVACDPPQQGDPGYPLVPVHLDKVV", "Sequence Length": 127, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal", "Anti-MRSA"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 14209.13, "PI": 8.64, "Hydrophobicity": -0.63, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Rudolph B, Podschun R, Sahly H, Schubert S, SchrÃ¶der JM, Harder J.2006", "Reference": "Antimicrob Agents Chemother. 2006 Sep;50(9):3194-6.Pub-Med.GenBank:AEX57301.1", "Title": "Identification of RNase 8 as a novel human antimicrobial protein"}], "Frequent Amino Acids": "PKS", "Absent Amino Acids": "OU", "Basic Residues": 19, "Acidic Residues": 9, "Hydrophobic Residues": 50, "Polar Residues": 80, "Positive Residues": 19, "Negative Residues": 9, "Net Charge": 10, "Comments": "Activity: Has ribonuclease activity. A broad spectrum AMP. Active against Gram+ S. aureus strains ATCC 6538, 12600, 33593 (MRSA), 43300 (MRSA) (MBC 0.9-1.8 uM), S. epidermidis ATCC 14990 (MBC 0.9-1.8 uM), S. pyogenes ATCC 12344 (MBC 0.9-3.5 uM), S-pneumoniae ATCC 33400 (MBC>7 uM), E. faecalis ATCC 29212 (MBC 0.4-1.8 uM), E. faecalis ATCC 51299 (VRE) (MBC 3.5 uM), E. faecium DSM 2146, E. faecium clinical isolate (anti-VRE) (MBC 0.4 uM), E-faecium clinical isolate (VRE) (MBC>7 uM), Gram- E. coli ATCC 25922 (MIC 0.2-0.9 uM), E. coli ATCC 35218 (MBC 0.2 uM), E. coli ATCC 11775 (MBC 0.4 uM), K. pneumoniae ATCC 13882 (MBC 0.2-0.9 uM), K. pneumoniae ATCC 13883 (MBC 0.1-0.2 uM), E. cloacae ATCC 13047 (MBC 7 uM), S-marcescens NCTC 10211 (MBC>7.0 uM), C-freundii NCTC 9750 (MBC > 7.0 uM), P. aeruginosa ATCC 10145 and clincal (MBC 0.2-0.9 uM), P-fluorescens NCTC 10038 (MBC>7 uM), B-cepacia ATCC 25416 (MBC>7 uM), A. baumannii ATCC 19606 (MBC 0.2 uM), and fungus C. albicans (MBC 1.8 uM).Activity Robustness: Active also at 100 mM NaCl. However, the activity is reduced at 150 mM salt (salt-sensitive).Toxicity: little hemolysis till 28 uM.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_16924", "Similarity": 0.9555555555555556, "Sequence": "KPKDMTSSQWFKTQHVQPSPQASNSAMSIINKYTERSKDLNTFLH"}, {"SPADE_ID": "SPADE_N_10142", "Similarity": 0.8450704225352113, "Sequence": "KPKGMTSSQWFKIQHMQPSPQACNSAMKNINKHTKRCKDLNTFLHEPFSSVAATCQTPKIACKNGDKNCHQ"}, {"SPADE_ID": "SPADE_UN_29082", "Similarity": 0.8450704225352113, "Sequence": "KPKGMTSSQWFKIQHMQPSPQACNSAMKNINKHTKRCKDLNTFLHEPFSSVAATCQTPKIACKNGDKNCHQ"}]}}}